---
title: "Varegacestat (AL102) in Desmoid tumors: Product information and disease description: Disease burden"
description: "Formulary evidence on Varegacestat (AL102, BMS-986115) in Desmoid tumors: Disease burden. Covers Humanistic burden and health-related quality of life, Economic burden and healthcare resource utilization, Economic impact on families, and Economic impact of diagnostic testing. 56 evidence topics quoted from 33 sources."
canonical: "https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/product-information-and-disease-description/disease-burden"
published: "2026-11-18T22:42:04-05:00"
modified: "2026-11-18T22:42:04-05:00"
---

# Varegacestat (AL102) in Desmoid tumors: Product information and disease description: Disease burden

<a id="heading-2.2.1.8"></a>

## 2.2.1.8 Burden of Desmoid tumors

- [Humanistic burden and health-related quality of life](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/product-information-and-disease-description/humanistic-burden-and-health-related-quality-of-life)

- [Economic burden and healthcare resource utilization](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/product-information-and-disease-description/economic-burden-and-healthcare-resource-utilization)

- [Economic impact on families](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/product-information-and-disease-description/economic-impact-on-families)

- [Economic impact of diagnostic testing](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/product-information-and-disease-description/economic-impact-of-diagnostic-testing)

## Related pages
- [Varegacestat (AL102): Desmoid tumors](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors) · [Markdown](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors.md)
- [Varegacestat (AL102) in Desmoid tumors: Terms and abbreviations](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/terms-and-abbreviations.md)
- [Varegacestat (AL102): Desmoid tumors](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/executive-summary) · [Markdown](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/executive-summary.md)
- [Varegacestat (AL102) in Desmoid tumors: Product information and disease description](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/product-information-and-disease-description.md)
- [Varegacestat (AL102) in Desmoid tumors: Clinical evidence](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/clinical-evidence.md)
- [Varegacestat (AL102) in Desmoid tumors: Economic information and modeling report](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/economics) · [Markdown](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/economics.md)
- [Varegacestat (AL102) in Desmoid tumors: References](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/references) · [Markdown](https://www.evicenter.com/drugs/varegacestat--desmoid-tumors/references.md)
